Back to Search

KENNETH LICHTENSTEIN, MD

MD

Infectious Disease Physician

NPI: 1740370428Individual

Specialties, Licenses & Credentials

Infectious Disease PhysicianPrimary

Internal Medicine — Infectious Disease

Code: 207RI0200X

19010(CO)C138127(CA)

Research & Publications (20)

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.
PMID 15614705·Clin Infect Dis·2005
8-other
Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients.
PMID 12514413·J Acquir Immune Defic Syndr·2003
8-other
Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.
PMID 11504960·AIDS·2001
4-observational
Antiretroviral treatment interruptions and risk of non-opportunistic diseases.
PMID 19358778·Curr HIV/AIDS Rep·2009
6-review
Human immunodeficiency virus-associated lipoatrophy: letting the genome out of the bottle.
PMID 18419348·J Infect Dis·2008
8-other
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency.
PMID 17971714·J Acquir Immune Defic Syndr·2008
8-other
HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.
PMID 17634130·AIDS Res Ther·2007
8-other
HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms.
PMID 17597538·AIDS Res Ther·2007
8-other
Atazanavir-containing renal calculi in an HIV-infected patient.
PMID 17457108·AIDS·2007
5-case
Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection.
PMID 16553510·Pharmacotherapy·2006
5-case
96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
PMID 16514301·AIDS·2006
4-observational
Redefining lipodystrophy syndrome: risks and impact on clinical decision making.
PMID 16010159·J Acquir Immune Defic Syndr·2005
6-review
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
PMID 15821394·AIDS·2005
3-trial
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
PMID 15668540·AIDS·2005
8-other
The case for earlier treatment of HIV infection.
PMID 15578373·Clin Infect Dis·2004
6-review
A 7-year longitudinal analysis of IL-2 in patients treated with highly active antiretroviral therapy.
PMID 15577556·AIDS·2004
4-observational
The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities.
PMID 14986261·Clin Infect Dis·2004
6-review
Total energy expenditure and carbohydrate oxidation are increased in the human immunodeficiency virus lipodystrophy syndrome.
PMID 12759894·Metabolism·2003
3-trial
Adipocyte-derived hormone levels in HIV lipodystrophy.
PMID 12713059·Antivir Ther·2003
8-other
Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.
PMID 11600828·AIDS·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4791 E PALM CANYON DR STE 200
PALM SPRINGS, CA 92264

Location

Practice Location

4791 E PALM CANYON DR STE 200, PALM SPRINGS, CA
(760) 834-7950

Quick Facts

NPI
1740370428
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile